Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases

Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.

408 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases trial results

Active, Not Recruiting

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

NCT06768671

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site North Little Rock, Arkansas, United States
  • Clinical Site Stanford, California, United States
  • Clinical Site Washington D.C., District of Columbia, United States
  • Clinical Site Hollywood, Florida, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

NCT06526182

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Hospital General Universitario Dr. Balmis Alicante, Spain
  • Hospital del Mar - Parc de Salut Mar Barcelona, Spain
  • Hospital Universitario Clínico San Cecilio Granada, Spain
  • Consorci Hospital General Universitari de València Valencia, Spain
View Trial Details
Active, Not Recruiting

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

NCT02682511

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +8 more
Locations
  • The Universtity of Arizona Arthrtis Center Tucson, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Cleveland Clinic - Florida Weston, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)

NCT06162728

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +13 more
Locations
  • Site 118 Birmingham, Alabama, United States
  • Site 108 Little Rock, Arkansas, United States
  • Site 105 San Diego, California, United States
  • Site 113 Miami, Florida, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

NCT04711252

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Harbor City, California, United States
  • Research Site Solvang, California, United States
View all 263 locations
View Trial Details

Related conditions